ITMI20132169A1 - Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata - Google Patents

Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata

Info

Publication number
ITMI20132169A1
ITMI20132169A1 IT002169A ITMI20132169A ITMI20132169A1 IT MI20132169 A1 ITMI20132169 A1 IT MI20132169A1 IT 002169 A IT002169 A IT 002169A IT MI20132169 A ITMI20132169 A IT MI20132169A IT MI20132169 A1 ITMI20132169 A1 IT MI20132169A1
Authority
IT
Italy
Prior art keywords
copd
prevention
treatment
composition
related symptoms
Prior art date
Application number
IT002169A
Other languages
English (en)
Inventor
Giovanni Scapagnini
Enrico Sortino
Original Assignee
Thompson S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thompson S R L filed Critical Thompson S R L
Priority to IT002169A priority Critical patent/ITMI20132169A1/it
Priority to EP14833259.6A priority patent/EP3086659B1/en
Priority to PCT/IB2014/067148 priority patent/WO2015092763A1/en
Publication of ITMI20132169A1 publication Critical patent/ITMI20132169A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1722—Plasma globulins, lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
IT002169A 2013-12-20 2013-12-20 Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata ITMI20132169A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT002169A ITMI20132169A1 (it) 2013-12-20 2013-12-20 Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata
EP14833259.6A EP3086659B1 (en) 2013-12-20 2014-12-19 Nutritional composition for the prevention and treatment of copd and related symptoms
PCT/IB2014/067148 WO2015092763A1 (en) 2013-12-20 2014-12-19 Nutritional composition for the prevention and treatment of copd and related symptoms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002169A ITMI20132169A1 (it) 2013-12-20 2013-12-20 Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata

Publications (1)

Publication Number Publication Date
ITMI20132169A1 true ITMI20132169A1 (it) 2015-06-21

Family

ID=50116013

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002169A ITMI20132169A1 (it) 2013-12-20 2013-12-20 Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata

Country Status (3)

Country Link
EP (1) EP3086659B1 (it)
IT (1) ITMI20132169A1 (it)
WO (1) WO2015092763A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114246849A (zh) * 2014-05-12 2022-03-29 奥斯生化药剂公司 姜黄素-肽缀合物及其制剂
JP7097023B2 (ja) * 2018-10-31 2022-07-07 サントリーホールディングス株式会社 ペプチド、唾液腺の萎縮又は機能低下の抑制又は回復用組成物及び肺の萎縮又は機能低下の抑制又は回復用組成物
US11925606B2 (en) * 2020-01-17 2024-03-12 Sami-Sabinsa Group Limited Compositions for managing chronic obstructive pulmonary disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003166A1 (en) * 2001-04-27 2003-01-02 Goen Group, Inc. Immunity enhancing supplements for lung support

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003166A1 (en) * 2001-04-27 2003-01-02 Goen Group, Inc. Immunity enhancing supplements for lung support

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KHERADPEZHOUH E ET AL: "Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 628, no. 1-3, 25 February 2010 (2010-02-25), pages 274 - 281, XP026851677, ISSN: 0014-2999, [retrieved on 20091115] *
RAHMAN I ET AL: "ANTIOXIDANT THERAPEUTIC TARGETS IN COPD", CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBLISHER, US, vol. 7, no. 6, 1 June 2006 (2006-06-01), pages 707 - 720, XP009069239, ISSN: 1389-4501, DOI: 10.2174/138945006777435254 *

Also Published As

Publication number Publication date
WO2015092763A1 (en) 2015-06-25
EP3086659B1 (en) 2019-07-17
EP3086659A1 (en) 2016-11-02

Similar Documents

Publication Publication Date Title
IL273815B (en) Secondary vaccine particles for the treatment of inflammation
IL256624B (en) Pharmaceutical compounds and preparations thereof for the treatment of inflammatory disorders
DK3076967T3 (da) Fremgangsmåder til behandling af residuelle symptomer på skizofreni
IL245508A0 (en) Dosage form of sublingual cannabis and methods for its preparation and use
ZA201604110B (en) New treatment of chronic ulcers
HUE054577T2 (hu) Fenfluramin Dravet-szindróma kezelésében történõ alkalmazásra
DK3010503T3 (da) Hidtil ukendte bicykliske bromodomæne-inhibitorer
EP2997036A4 (en) CLEANING OF RECOMBINANT MANUFACTURED POLYPEPTIDES
HK1217896A1 (zh) 用於治療廣泛性發展障礙的複合物及方法
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
DK3024428T3 (da) Sammensætninger og fremgangsmåder til dental mineralisering
DK3071053T3 (da) Præbiotisk sammensætning
HK1221166A1 (zh) 炎症性病症的治療
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
DK2976101T3 (da) Behandlingsfremgangsmåde
ITMI20132169A1 (it) Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata
DK3068428T3 (da) Annexin-ii-variant-sammensætninger og fremgangsmåder
FI10329U1 (fi) Kaasujen käsittelylaitteisto
TH1501001181A (th) องค์ประกอบสำหรับรักษาโรคสะเก็ดเงิน
DK3041506T3 (da) Behandlingsfremgangsmåde
TH1401007179A (th) องค์ประกอบและการใช้ของมันเพื่อป้องกันและรักษาตับอักเสบบี
GB201316698D0 (en) Use of tri-substituted glycerol compounds for prevention and treatment of allo-immune disorders
FI10307U1 (fi) Järjestely kiskoliikennevaihteeseen